Project: Advanced Inhalation Model for Drug Discovery on Chip

Acronym AIM4DoC (Reference Number: 12977)
Duration 01/08/2019 - 03/08/2022
Project Topic ALVEOLIX together with partners aim to develop the world’s first inhalation exposure model on a lung-on-chip. AIM4DoC can be used for inhalation toxicology studies, environmental risk assessment, or pre-clinical safety assessment of new drugs. ALVEOLIX, expert for organ-on-chip technology, will join forces with VITROCELL, market leader for in-vitro exposure systems. After successful validation, this groundbreaking product will improve the drug discovery process and reduce animal testing.
Network Eurostars 2
Call Eurostars Cut–off 10

Project partner

Number Name Role Country
1 AlveoliX AG Coordinator Switzerland
2 Universität Bern Partner Switzerland
3 VITROCELL Systems GmbH Partner Germany
4 Helmholtz-Zentrum für Infektionsforschung Partner Germany